Oncologists use measurement of response as an indicator that the therapy they are administering is effective. This information can then be used to decide whether to continue, change, or stop therapy ...
Expert panelists consider how to define response to disease-modifying therapies and discuss the threshold for treatment ineligibility due to lack of response. Neil Minkoff, MD: At some point, we are ...
...how can this be reconciled to allow the field of oncology to move forward We are all familiar with the metrics of tumour shrinkage and time to the development of disease progression as important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results